Biodegradable cisplatin microspheres for direct brain injection: Preparation and characterization

Pharmaceutical Development and Technology

Volumn 2, Issue 1, 1997, Pages 53-65

  García Contreras, Lucila ^a   Abu Izza, Khawla ^a   Lu, D Robert ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Biodegradable microspheres; Cisplatin; Intracerebral delivery; Malignant glioma; Protein adsorption

Indexed keywords

CISPLATIN; MICROSPHERE;

ARTICLE; DRUG METABOLISM; DRUG RELEASE; DRUG TRANSFORMATION; GLIOBLASTOMA; INTRACEREBRAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0031401984     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459709022609     Document Type: Article

References (33)

1. R. G. Evans. The role of radiation therapy in the treatment of adult brain tumors, in R. A. Morantz and J. W. Walsh (eds.), Brain Tumors: A Comprehensive Text, Marcel Dekker, New York, 1994, pp. 643-657.
2. The Johns Hopkins Medical Handbook: The 100 Major Medical Disorders of People over the Age of 50, Prepared by the editors of the Jonhs Hopkins medical letter health after 50. Rebus: Random House, New York, 1992, pp. 131-136.
3. M. Chasin, G. Hollenbeck, H. Brem, S. Grossman, M. Colvin, and R. Langer, Interstitial drug therapy for brain tumors: A case study, Drug. Dev. Ind. Pharm., 16(18): 2579-2594 (1990).
4. H. Brem, M. S. Mahaley, N. A. Vick, K. L. Black, S. C. Schold, P. C. Burger, A. H. Friedman, I. S. Ciric, T. W. Eller, J. W. Cozzens and J. N. Kenealy, Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas, J. Neurosurg., 74(3): 441-446 (1991).
5. S. A. Grossman, C. Reinhard, M. Colvin, M. Chasin, R. Brundrett, R. J. Tamargo and H. Brem, The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers, J. Neurosurg., 76(4): 640-647 (1992).
6. R. J. Tamargo, J. S. Myseros, J. I. Epstein, M. B. Yang, M. Chasin and H. Brem, Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain, Cancer Res., 53(1): 329-333 (1993).
7. M. P. Wu, J. A. Tamada, H. Brem and R. Langer, In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy, J. Biomed. Mat. Res., 28(3):387-395 (1994).
8. M. Boisdron-Celle, P. Menei and J. P. Benoit, Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers, J. Pharm. Pharmacol., 47:108-114 (1995).
9. P. Menei, A. Croué, A. Pouplard-Barthelaix, and J. P. Benoit, Fate and biocompatibility of three types of microspheres implanted into the brain, J. Biomed. Mat. Res., 28:1079-1085 (1994).
10. P. Menei, J. P. Benoit, M. Boisdron-Celle, D. Foumier, P. Mercier and G. Guy, Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres, Neurosurgery, 34(6):1058-1063 (1994).
11. P. Calabresi and R. E. Parks, Chemotherapy of neoplastic diseases, in A. Goodman Gilman and L.S. Goodman (eds.), The Pharmacological Basis of Therapeutics, Macmillan Publishing Co., New York, 1985, pp. 1290-1291.
12. W. R. Shapiro, Chemotherapy of malignant gliomas: Studies of the BTCG, Rev. Neurol. Paris., 148:428-434 (1992).
13. L. R. Rogers, J. B.Purvis, R. J. Lederman, S. A. Rosenbloom, R. L. Tomsak, M. L. Estes, M. Magdinec, S. V. Medendorp, and J. M. Boyett, Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma, Cancer, 68(1):15-21 (1991).
14. A. P. Kyritsis, Chemotherapy for malignant gliomas, Oncology, 7(9):93-100 (1993).
15. P. Menei, V. Daniel, C. Montero-Menei, M. Brouillard, A. Puoplard-Barthelaix, and J. P. Benoit, Biodegradation and brain tissue reaction to poly(D,L-lactide-coglycolide) microspheres, Biomaterials, 14(6):470-478 (1993).
16. P. J. Watts, M. C. Davies, and C. D. Melia, Microencapsulation using emulsification/solvent evaporation: An overview of techniques and applications, Crit. Rev. Ther. Drug Carrier Syst., 7(3):235-259 (1990).
17. 2 with changes in ventillation, Neurosurgery, 34(3):466-470 (1994).
18. W. A. J. Dewaal, F. J. M. J. Maessen, and J. C. Kraak, Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological media, J. Pharm. Biomed. Anal., 8(1):1-30 (1990).
19. C. Li, D. J. Yang, S. Nikiforow, W. Tansey, L. R. Kuang, K. C. Wright, and S Wallace, Formation and characterization of cisplatin loaded poly(benzyl-L-glutamate) microspheres for chemoembolization, Pharm. Res., 11(12):1792-1799 (1994).
20. R. Jalil and J. R. Nixon, Microencapsulation using poly(L-lactic acid). II. Preparative variables affecting microcapsule properties, J. Microencap., 7(1):25-39 (1990).
21. M. Cavalier, J. P. Benoit, and C. Thies, The formation and characterization of hydrocortisone-loaded poly(±lactide) microspheres, J. Pharm. Pharmacol., 38(4):249-253 (1986).
22. R. Jalil and J. R. Nixon, Microencapsulation using poly(L-lactic acid). III. Effect of polymer molecular weight on the microcapsule properties, J. Microencap., 7(1):41-52 (1990).
23. P. Saini, P. Greenspan, and D. R. Lu, Adsorption of brain proteins on the surface of poly (D,L lactide-co-glycolide (PLGA) microspheres, Pharm. Res., (submitted for publication).
24. K. Abu-Izza and D. R. Lu, Effect of gastrointestinal protein adsorption on the in vitro release of AZT from ethylcellulose microspheres (unpublished data, manuscript in preparation).
25. T. Tsai, R. Mehta, and P. DeLuca, Adsorption of peptides to poly(D,L-lactide-co-glycolide). I. Effect of physical factors on the adsorption, Int. J. Pharm., 127:31-42 (1996).
26. J. F. Fitzgerald and O. I. Corrigan, Mechanisms governing drug release from poly-α-hydroxy aliphatic esters. Dialtiazem base release from poly(lactide-co-glycolide) delivery systems, in M. A. El-Nokaly, D. M. Piatt, and B. A. Charpentier (eds.), Polymeric Delivery Systems. Properties and Applications, American Chemical Society, 1993, pp. 311-326.
27. M. Nakano, N. Wakiyama, T. Kojima, K. Juni, and S. Inoue, Biodegradable microspheres for prolonged local anesthesia. in S. S. Davis, L. Illum, J. G. McVie, and E. Tomlinson (eds.), Microspheres and Drug Therapy, Elsevier Science Publishers, Amsterdam, The Netherlands, 1984, pp. 327-335.
28. K. Juni and M. Nakano, Poly(lactic acid) microspheres as drug carrier systems, in L. Illum and S. S. Davis (eds.), Polymers in Controlled Drug Delivery, Bath Press, Bath, UK, 1987, pp. 49-59.
29. Y. Ogawa, H. Okada, M. Yamamoto, and T. Shimamoto, In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acid or copoly(lactic/glycolic) acids and in vivo degradation of these polymers, Chem. Pharm. Bull., 36(7):2576-2581 (1988).
30. D. A. Wood, Biodegradable drug delivery systems, Int. J. Pharm., 7(3):1-18 (1980).
31. C. G. Pitt, M. M. Gratzl, G. L. Kimmel, J. Surles, and A. Schindler, Aliphatic polyesters. II. The degradation of poly(D,L-lactide), poly(ε-caprolactone), and their copolymers in vivo, Biomaterials, 2(10):215-220. (1981).
32. E. A. Schmitt, D. R. Flanagan, and R. J. Linhardt, Degradation and release properties of pellets fabricated from three comercial poly(D,L-lactide-co-glycolide) biodegradable polymers, J. Pharm. Sci., 82(3):326-329 (1993).
33. C. G. Piatt, M. G. Gratzi, A. R. Jeffcoat, R. Zweidinger, and A. Schindler, Sustained drug delivery systems. II. Factors affecting release rates from poly(ε-caprolactone) and related biodegradable polyesters, J. Pharm. Sci., 68(12):1534-1538 (1979).